Jon E. Grant to Drug Administration Schedule
This is a "connection" page, showing publications Jon E. Grant has written about Drug Administration Schedule.
Connection Strength
0.579
-
N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 May 01; 73(5):490-6.
Score: 0.122
-
The effect of self-regulated caffeine use on cognition in young adults. Hum Psychopharmacol. 2015 Mar; 30(2):123-30.
Score: 0.112
-
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
Score: 0.070
-
N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007 Sep 15; 62(6):652-7.
Score: 0.065
-
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
Score: 0.060
-
Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003; 19(1):85-109.
Score: 0.048
-
An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
Score: 0.046
-
Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry. 2001 Apr; 62(4):297-8.
Score: 0.043
-
Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
Score: 0.012